Read more: Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not...
Read more: Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not...
More here: Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020
See the original post here: Editas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate Update
Continued here: Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020
View post: Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Read the rest here: Better Choice Closes Third Tranche of Series F and Completes Equity Raise Totaling Cumulative $21.7M
See more here:RespireRx Pharmaceuticals Inc. Announces Appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows
See the article here: BioStem Technologies, Inc. Announces Launch of AEON™
Excerpt from: Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory...
See the original post here: Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Recent Comments